4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-24-000049
EVP Strategy and Corporate sold 6,710 shares at $134.41 ($901,896)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dolan Matthew Vincent EVP Strategy and Corporate | 2024-03-12 | Sale | −6,710 | $134.41 | $901,896 | 48,570 | D: show line 1 in the form |
| Open-market sales · 6,710 sh · avg $134.41 · $901,896 | |||||||
Loading xslF345X05/edgardoc.xml…